Neuropharmacology of Vestibular System Disorders

Publisher： Bentham Science Publishers

E-ISSN： 1875-6190|8|1|26-40

ISSN： 1570-159X

Source： Current Neuropharmacology, Vol.8, Iss.1, 2010-03, pp. : 26-40

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Functional genomics in neuropsychiatric disorders and in neuropharmacology

By Castrén Eero   Kontkanen Outi  

Expert Opinion on Therapeutic Targets, Vol. 6, Iss. 3, 2002-06 ,pp. : 363-374

Informa Healthcare

Access to resources Recommend Favorite

Ademetionine (S-adenosylmethionine) neuropharmacology: implications for drug therapies in psychiatric and neurological disorders

By Bottiglieri T.  

Expert Opinion on Investigational Drugs, Vol. 6, Iss. 4, 1997-04 ,pp. : 417-426

Informa Healthcare

Access to resources Recommend Favorite

Neuropharmacology of the Endocannabinoid Signaling System-Molecular Mechanisms, Biological Actions and Synaptic Plasticity

By  

Current Neuropharmacology, Vol. 5, Iss. 2, 2007-01 ,pp. : 81-97

Bentham Science Publishers

Access to resources Recommend Favorite

Neuropharmacology of Cannabinoid System: From Basic Science to Clinical Applications

By  

Current Neuropharmacology, Vol. 2, Iss. 1, 2004-01 ,pp. : 1-7

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (Hot Topics :Anxiety Disorders, Advances in Neurobiology and Neuropharmacology)

By  

Current Pharmaceutical Design, Vol. 18, Iss. 35, 2012-12 ,pp. : 5607-5607

Bentham Science Publishers

Access to resources Recommend Favorite